UNSPSC 51101937: Tafenoquine

This classification denotes an antimalarial agent with the molecular formula C24H28F3N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 262P8GS9L9, chemically known as 1,4-pentanediamine, n4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)- but generally known as tafenoquine, which bears US NIH Compound Identifier 115358. European Medicines Agency schedules Tafenoquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04666MIG.

UNSPSC 51101937 Tafenoquine, a Commodity code, shows minimal alignment between its nominal scope—a specific antimalarial pharmaceutical—and actual state and local procurement activity under the code. Recent solicitations tagged to this code encompass a broad spectrum of pharmaceutical and medical supply procurement: naloxone and drug deactivation systems, medical and first aid supplies for fire departments, generic multi-source pharmaceuticals and over-the-counter products through cooperative purchasing, and direct-to-manufacturer prescription program capabilities. State and local issuing bodies soliciting under this code include county health departments, municipal fire departments, state health and human services commissions, and cooperative purchasing alliances serving multiple jurisdictions. The work being bought ranges from emergency medical supplies (respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, bandaging materials) to naloxone distribution systems supporting community health initiatives, with procurement mechanisms including competitive sealed bids (IFB), Requests for Information (RFI), and cooperative RFP vehicles.

Recent activity spans Florida, Texas, Minnesota, and Oregon. The Seminole County, Florida IFB for naloxone and drug deactivation systems (1,900 units of naloxone and 800 Safe Drug Deactivation Systems annually, due July 26, 2023) and the City of Tampa IFB for medical and first aid supplies serving the Fire Department Rescue Division (169 line items, estimated contract value $700,000.00, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount, due March 13, 2026) represent recent municipal activity. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic multi-source pharmaceuticals and OTC products (proposals due March 26, 2026, serving state and local government facilities across Minnesota and Oregon) and the Texas Health and Human Services Commission RFI regarding direct-to-manufacturer prescriptions (response deadline April 3, 2026) reflect state-level and multi-jurisdictional demand. The code itself does not appear to drive procurement strategy—the mismatch between tafenoquine and the actual solicitations suggests tagging inconsistency or system configuration issues rather than genuine market demand for this specific antimalarial.